Effect of dupilumab on allergic contact dermatitis and patch testing - 07/05/21
Doi : 10.1016/j.jaad.2021.02.044
Christine E. Jo, BSc a, Asfandyar Mufti, MD b, Muskaan Sachdeva, BHSc c, Melanie Pratt, MD, FRCPC d, Jensen Yeung, MD, FRCPC b, e, f, g, ⁎ 
a Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
b Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
c Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
d Division of Dermatology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
e Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada
f Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
g Probity Medical Research Inc, Waterloo, Ontario, Canada
∗Correspondence to: Jensen Yeung, MD, FRCPC, Division of Dermatology, Women's College Hospital, 76 Grenville Street, Fifth Floor, Toronto, ON M5S 1B2, CanadaDivision of DermatologyWomen's College Hospital76 Grenville Street, Fifth FloorTorontoONM5S 1B2Canada
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 6
P. 1772-1776 - juin 2021 Retour au numéro
Article précédent
- Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis
- Lauren K. Rangel, Payal Shah, Kristen Lo Sicco, Avrom S. Caplan, Alisa Femia
- Disparities in melanoma stage at diagnosis in Arizona: A 10-year Arizona Cancer Registry study
- Jenna E. Koblinski, Philip Maykowski, Nathalie C. Zeitouni
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?